Skip to main content
Premium Trial:

Request an Annual Quote

OpGen, Detroit Lab to Study Brain Tumor DNA

NEW YORK, Feb. 19 (GenomeWeb News) - OpGen will use its optical-mapping technology to help the HermelinBrainTumorCenterstudy oligodendrogliomas, the groups said today.

 

OpGen said it has begun an optical mapping study of the tumor that is aimed at helping researchers at Detroit-based Hermelin identify lesions in a tumor's genome "to determine what is happening at the DNA level and how well a patient will respond to treatment."

 

According to Oliver Bogler, an associate scientist at the HermelinCenter, deletions on chromosome 1p and 19q of the tumor "correlate strongly with response to a range of therapies," and that "it is crucial to understand the nature of these rearrangements."

 

"The fact that these deletions affect response to such different treatments, including various drug combinations and radiotherapy, indicates that something fundamental is going on here, and understanding these events could be crucial in developing new treatments for this, and possibly other lethal cancers," Bogler said in a statement.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.